Efficacy and Safety of Ambrisentan in Children 8-18yrs

Clinical trial NCT01332331 · TERMINATED

Trial details

NCT number: NCT01332331
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension, Pulmonary

Start date: 2011-01-04
Primary completion: 2013-11-12
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.